Outset Medical (OM) Net Income towards Common Stockholders (2019 - 2026)
Outset Medical (OM) reported Net Income towards Common Stockholders of -$19.0 million for Q1 2026, up 26.39% year-over-year from -$15.0 million in Q1 2025, and up 2.63% quarter-over-quarter from -$19.5 million in Q4 2025.
Outset Medical (OM) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Net Income towards Common Stockholders data on file, last reported at -$19.0 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$19.0 million, up 26.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$74.8 million (up 34.24% YoY), and the FY2025 annual result was -$81.7 million, up 36.2% from the prior year.
- Net Income towards Common Stockholders improved to -$19.0 million in Q1 2026 per OM's latest filing, from -$19.5 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$17.8 million in Q3 2025 and troughed at -$46.2 million in Q3 2023.
- A 5-year average of -$33.2 million and a median of -$36.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders tumbled 45.12% in 2022, then jumped 46.19% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$41.4 million in 2022, then grew by 6.86% to -$38.6 million in 2023, then jumped by 33.58% to -$25.6 million in 2024, then gained by 23.98% to -$19.5 million in 2025, then grew by 2.63% to -$19.0 million in 2026.
- Business Quant data shows OM's Net Income towards Common Stockholders at -$19.0 million in Q1 2026, -$19.5 million in Q4 2025, and -$17.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Outset Medical | 81,759.85 | -286.56 Mn | 12.10 Mn | -18.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.98 Mn |
| Dec 31, 2025 | -19.49 Mn |
| Sep 30, 2025 | -17.84 Mn |
| Jun 30, 2025 | -18.54 Mn |
| Mar 31, 2025 | -25.78 Mn |
| Dec 31, 2024 | -25.64 Mn |
| Sep 30, 2024 | -27.94 Mn |
| Jun 30, 2024 | -34.45 Mn |
| Mar 31, 2024 | -39.94 Mn |
| Dec 31, 2023 | -38.60 Mn |
| Sep 30, 2023 | -46.18 Mn |
| Jun 30, 2023 | -44.05 Mn |
| Mar 31, 2023 | -43.97 Mn |
| Dec 31, 2022 | -41.44 Mn |
| Sep 30, 2022 | -40.78 Mn |
| Jun 30, 2022 | -43.84 Mn |
| Mar 31, 2022 | -36.89 Mn |
| Dec 31, 2021 | -41.23 Mn |
| Sep 30, 2021 | -30.47 Mn |
| Jun 30, 2021 | -30.21 Mn |